Additionally, the STAT3 (signal transducer and activator of transcription 3) signaling pathway, which is often highly active in glioma cells and contributes to drug resistance, was remarkably inhibited in Res/TMZ-treated GBM cells [243]. The gene discussed is STAT3; the disease is glioblastoma.